Breast cancer showing HER2 protein expression without HER2 gene amplification could be divided into two separate groups (HER2-low [IHC 1+ or 2+ and ISH-negative] and HER2-zero [IHC 0]) with different prognosis or pCR after neoadjuvant chemotherapy [17,18,19,20,21,22]. Here, ERBB2 is linked to breast carcinoma.